These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9648589)

  • 1. No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms.
    Shih YC; Kerr J; Hurst TG; Khoo SK; Ward BG; Chenevix-Trench G
    Gynecol Oncol; 1998 Jun; 69(3):210-3. PubMed ID: 9648589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
    Huan Z; Nakayama K; Nakayama N; Ishibashi M; Yeasmin S; Katagiri A; Purwana IN; Iida K; Maruyama R; Fukumoto M; Miyazaki K
    Oncol Rep; 2008 Mar; 19(3):775-81. PubMed ID: 18288415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.
    Sood AK; Holmes R; Hendrix MJ; Buller RE
    Cancer Res; 2001 Jun; 61(11):4371-4. PubMed ID: 11389062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
    Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
    Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
    Fukumoto M; Nakayama K
    Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
    Brown MR; Chuaqui R; Vocke CD; Berchuck A; Middleton LP; Emmert-Buck MR; Kohn EC
    Gynecol Oncol; 1999 Jul; 74(1):98-102. PubMed ID: 10385558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent microsatellite instability in epithelial borderline ovarian tumors.
    Tangir J; Loughridge NS; Berkowitz RS; Muto MG; Bell DA; Welch WR; Mok SC
    Cancer Res; 1996 Jun; 56(11):2501-5. PubMed ID: 8653685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High grade sarcomas are associated with microsatellite instability (chromosom 12) and loss of heterozygosity (chromosom 2).
    Rucińska M; Kozłowski L; Pepiński W; Skawrońska M; Janica J; Wojtukiewic MZ
    Med Sci Monit; 2005 Feb; 11(2):BR65-8. PubMed ID: 15668629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma.
    Nakayama K; Takebayashi Y; Namiki T; Tamahashi N; Nakayama S; Uchida T; Miyazaki K; Fukumoto M
    Int J Cancer; 2001 Nov; 94(4):605-9. PubMed ID: 11745452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin.
    Dhillon VS; Aslam M; Husain SA
    Clin Cancer Res; 2004 Aug; 10(16):5537-45. PubMed ID: 15328194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors.
    Nishimura N; Hachisuga T; Nabeshima K; Kawarabayashi T
    Int J Oncol; 2005 Dec; 27(6):1519-26. PubMed ID: 16273207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ; Li JC
    Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.